ナルコレプシー(居眠り病)治療薬の世界市場2022年-2026年

Technavioが発行した調査報告書(IRTNTR73929-22)
◆英語タイトル:Global Narcolepsy Drugs Market 2022-2026
◆商品コード:IRTNTR73929-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年7月22日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、 ヨーロッパ、 アジア、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥332,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

Technavio社の最新調査レポートによると、世界のナルコレプシー(居眠り病)治療薬市場規模は2022年から2026年までの間に年平均9.1%成長し、16.0億ドルに達する見通しです。当書では、ナルコレプシー(居眠り病)治療薬の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(脱力発作併発型ナルコレプシー、非脱力発作併発型ナルコレプシー、二次ナルコレプシー)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、本書に掲載されている企業情報には、Alkermes Public Ltd. Co.、Apotex Inc.、Aurobindo Pharma Ltd.、Avadel Pharmaceuticals plc、Axsome Therapeutics Inc.、BIOPROJET、Cadila Pharmaceuticals Ltd.、Don Valley Pharma、Graymark Healthcare Inc.、Jabs Biotech Pvt. Ltd.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のナルコレプシー(居眠り病)治療薬市場規模:種類別(脱力発作併発型ナルコレプシー、非脱力発作併発型ナルコレプシー、二次ナルコレプシー)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析
【レポートの概要】

Global Narcolepsy Drugs Market 2022-2026

Technavio has been monitoring the narcolepsy drugs market and is poised to grow by $ 1.60 bn during 2022-2026, accelerating at a CAGR of 9.1% during the forecast period. Our report on the narcolepsy drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising product launches and clinical trials, rising cases of narcolepsy in adults, and a rising number of studies to understand the cause and treatment of narcolepsy.

The narcolepsy drugs market analysis includes the type segment and geographic landscape.
Technavio’s narcolepsy drugs market is segmented as below:

By Type
• Narcolepsy with cataplexy
• Narcolepsy without cataplexy
• Secondary narcolepsy

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancement in narcolepsy treatment as one of the prime reasons driving the narcolepsy drugs market growth during the next few years. Also, increasing demand for non-pharmacological therapies and combination treatments for narcolepsy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on narcolepsy drugs market covers the following areas:
• Narcolepsy drugs market sizing
• Narcolepsy drugs market forecast
• Narcolepsy drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading narcolepsy drugs market vendors that include Alkermes Public Ltd. Co., Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., BIOPROJET, Cadila Pharmaceuticals Ltd., Don Valley Pharma, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals Plc, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., Shionogi and Co. Ltd., Somacare, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd. Also, the narcolepsy drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all future growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/narcolepsy-drugs-market-industry-analysis

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type – Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Narcolepsy with cataplexy – Market size and forecast 2021-2026
o Exhibit 28: Chart on Narcolepsy with cataplexy – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Narcolepsy with cataplexy – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Narcolepsy with cataplexy – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Narcolepsy with cataplexy – Year-over-year growth 2021-2026 (%)
o 5.4 Narcolepsy without cataplexy – Market size and forecast 2021-2026
o Exhibit 32: Chart on Narcolepsy without cataplexy – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Narcolepsy without cataplexy – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Narcolepsy without cataplexy – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Narcolepsy without cataplexy – Year-over-year growth 2021-2026 (%)
o 5.5 Secondary narcolepsy – Market size and forecast 2021-2026
o Exhibit 36: Chart on Secondary narcolepsy – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Secondary narcolepsy – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Secondary narcolepsy – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Secondary narcolepsy – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.10 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.11 France – Market size and forecast 2021-2026
o Exhibit 78: Chart on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Alkermes Public Ltd. Co.
o Exhibit 89: Alkermes Public Ltd. Co. – Overview
o Exhibit 90: Alkermes Public Ltd. Co. – Product / Service
o Exhibit 91: Alkermes Public Ltd. Co. – Key news
o Exhibit 92: Alkermes Public Ltd. Co. – Key offerings
o 10.4 Avadel Pharmaceuticals plc
o Exhibit 93: Avadel Pharmaceuticals plc – Overview
o Exhibit 94: Avadel Pharmaceuticals plc – Business segments
o Exhibit 95: Avadel Pharmaceuticals plc – Key news
o Exhibit 96: Avadel Pharmaceuticals plc – Key offerings
o Exhibit 97: Avadel Pharmaceuticals plc – Segment focus
o 10.5 Axsome Therapeutics Inc.
o Exhibit 98: Axsome Therapeutics Inc. – Overview
o Exhibit 99: Axsome Therapeutics Inc. – Product / Service
o Exhibit 100: Axsome Therapeutics Inc. – Key offerings
o 10.6 BIOPROJET
o Exhibit 101: BIOPROJET – Overview
o Exhibit 102: BIOPROJET – Product / Service
o Exhibit 103: BIOPROJET – Key offerings
o 10.7 Jazz Pharmaceuticals Plc
o Exhibit 104: Jazz Pharmaceuticals Plc – Overview
o Exhibit 105: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 106: Jazz Pharmaceuticals Plc – Key news
o Exhibit 107: Jazz Pharmaceuticals Plc – Key offerings
o 10.8 Shionogi and Co. Ltd.
o Exhibit 108: Shionogi and Co. Ltd. – Overview
o Exhibit 109: Shionogi and Co. Ltd. – Product / Service
o Exhibit 110: Shionogi and Co. Ltd. – Key offerings
o 10.9 Somacare
o Exhibit 111: Somacare – Overview
o Exhibit 112: Somacare – Product / Service
o Exhibit 113: Somacare – Key offerings
o 10.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 114: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 115: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 116: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 118: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 119: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 120: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 121: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 122: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 XWPharma Ltd.
o Exhibit 123: XWPharma Ltd. – Overview
o Exhibit 124: XWPharma Ltd. – Product / Service
o Exhibit 125: XWPharma Ltd. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Narcolepsy with cataplexy – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Narcolepsy with cataplexy – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Narcolepsy with cataplexy – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Narcolepsy with cataplexy – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Narcolepsy without cataplexy – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Narcolepsy without cataplexy – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Narcolepsy without cataplexy – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Narcolepsy without cataplexy – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Secondary narcolepsy – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Secondary narcolepsy – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Secondary narcolepsy – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Secondary narcolepsy – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Alkermes Public Ltd. Co. – Overview
Exhibits90: Alkermes Public Ltd. Co. – Product / Service
Exhibits91: Alkermes Public Ltd. Co. – Key news
Exhibits92: Alkermes Public Ltd. Co. – Key offerings
Exhibits93: Avadel Pharmaceuticals plc – Overview
Exhibits94: Avadel Pharmaceuticals plc – Business segments
Exhibits95: Avadel Pharmaceuticals plc – Key news
Exhibits96: Avadel Pharmaceuticals plc – Key offerings
Exhibits97: Avadel Pharmaceuticals plc – Segment focus
Exhibits98: Axsome Therapeutics Inc. – Overview
Exhibits99: Axsome Therapeutics Inc. – Product / Service
Exhibits100: Axsome Therapeutics Inc. – Key offerings
Exhibits101: BIOPROJET – Overview
Exhibits102: BIOPROJET – Product / Service
Exhibits103: BIOPROJET – Key offerings
Exhibits104: Jazz Pharmaceuticals Plc – Overview
Exhibits105: Jazz Pharmaceuticals Plc – Product / Service
Exhibits106: Jazz Pharmaceuticals Plc – Key news
Exhibits107: Jazz Pharmaceuticals Plc – Key offerings
Exhibits108: Shionogi and Co. Ltd. – Overview
Exhibits109: Shionogi and Co. Ltd. – Product / Service
Exhibits110: Shionogi and Co. Ltd. – Key offerings
Exhibits111: Somacare – Overview
Exhibits112: Somacare – Product / Service
Exhibits113: Somacare – Key offerings
Exhibits114: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits115: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits116: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits117: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits118: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits119: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits120: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits121: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits122: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits123: XWPharma Ltd. – Overview
Exhibits124: XWPharma Ltd. – Product / Service
Exhibits125: XWPharma Ltd. – Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ナルコレプシー(居眠り病)治療薬の世界市場2022年-2026年(Global Narcolepsy Drugs Market 2022-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆